In its latest move to address the ongoing opioid addiction epidemic, Independence Blue Cross said Tuesday it is removing member cost sharing — effective March 1 — for injectable and nasal spray formulations of naloxone. Naloxone blocks the effects of opioids and reverses an overdose when ...

Read more